Navigation Links
Neura Therapeutik Forms Business Units to Pursue Analgesic Market Opportunities

PRINCETON, N.J., July 31, 2012 /PRNewswire/ -- Neura Therapeutik, LLC, a privately held specialty pharmaceutical company, announced today the formation of two strategic business units to capitalize on current and future opportunities in the analgesic market. The formation of Neura Group, LLC and Neura Labs, LLC structures the company to efficiently pursue commercial services, in-licensing, and joint venture opportunities in the analgesic marketplace.

Established by former King and Pfizer executives in 2010, Neura Therapeutik brings expertise in commercialization and development of analgesics, primarily in the NSAID and opioid classes of the pain market. Management's past experience includes directing pain franchise build outs and launching some of the largest US analgesic brands including Duragesic® patch and Vicodin ES® tablets. The formation of the business units allows Neura the ability to fully leverage its expertise in the analgesic market and build strong working alliances with strategic operational partners.

Through in-licensing and joint venture arrangements, the Neura Labs business unit will focus on establishing a portfolio of analgesic products with unique characteristics that fulfill unmet market needs, reside in the opioid and more specifically the tamper-resistant segment, or that have a high therapeutic index, or other unique pharmacokinetic or functional characteristics.

The Neura Group business unit provides companies interested in entering the analgesic market with a highly experienced turn-key commercial infrastructure and leadership team capable of rapidly establishing a total US operational presence. Neura Group offers best-in-class functional area expertise in CMC, regulatory and manufacturing scale-up to sales, marketing, launch readiness and lifecycle management.

"There are many nuances associated with analgesic commercialization. A commercial team with experience navigating the US analgesic marketplace is critical for the success of any product seeking to enter this market," said John La Lota, CEO of Neura Therapeutik. "Neura Therapeutik's two strategic business units provide an efficient solution to companies requiring an analgesic experienced commercial team whether they wish to retain the asset and leverage our commercial expertise, or if they seek an experienced company as a licensing partner."

Duragesic® is a registered trademark of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Vicodin ES® is a registered trademark of Abbott Laboratories.


Neura Therapeutik, LLC
Greg Gironda: 

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Neura Therapeutik, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
2. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
3. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Sanovas Forms Scientific Advisory Board to Support Development of Lung Cancer Technology
6. BioSurplus Forms New Division for Auction Services
7. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. inVentiv Medical Management Forms Partnership with Vital Decisions
10. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
11. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
Post Your Comments:
(Date:11/24/2015)... st  Scientific Assembly and Annual Meeting of the Radiological Society of ... Chicago on Nov-29 th through Dec-4 th ... Assembly and Annual Meeting of the Radiological Society of ... on Nov-29 th through Dec-4 th , in ... its revolutionary whole body CZT digital SPECT/CT solution at the upcoming ...
(Date:11/24/2015)... Ontario , Nov. 24, 2015 Teledyne ... digital X-Ray image sensing technology, will introduce its CMOS ... Technical Exhibition , November 29 to December 3, at McCormick ... of dynamic detectors for diagnostic and interventional imaging will be ... Xineos family of advanced CMOS X-Ray detectors is ...
(Date:11/24/2015)... 2015  Boston Scientific Corporation (NYSE: BSX ) ... Healthcare Conference on December 8, in New ... vice president, Investor Relations, will participate in a 30-minute ... 8:35 a.m. ET. --> Susie Lisa , ... question-and-answer session with the host analyst beginning at approximately ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
(Date:11/24/2015)... ON (PRWEB) , ... November 24, 2015 , ... New ... Williams without a referral for dental implants at her Mississauga, ON practice. ... and experienced in the placement of dental implants. , Missing teeth can lead ...
(Date:11/24/2015)... FRANCISCO, CA (PRWEB) , ... November 24, 2015 ... ... half-cup sizes, has launched their Black Friday sale a week early, offering 40% ... continues to transform the intimate apparel industry through both mobile fit technology and ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... DMG Productions ... Ed Begley Jr., airing first quarter 2016 via Discovery Channel. Dates and show times ... the Province, and is in the business of producing and supplying medical marijuana pursuant ...
(Date:11/24/2015)... ... November 24, 2015 , ... It takes only three to five ... is critical that the first impression be positive and reflects business values. If a ... buy anything or want to return. They will also share their thoughts about a ...
Breaking Medicine News(10 mins):